| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |